These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. Constitutive activation of signal transducers and activators of transcription predicts vorinostat resistance in cutaneous T-cell lymphoma. Fantin VR; Loboda A; Paweletz CP; Hendrickson RC; Pierce JW; Roth JA; Li L; Gooden F; Korenchuk S; Hou XS; Harrington EA; Randolph S; Reilly JF; Ware CM; Kadin ME; Frankel SR; Richon VM Cancer Res; 2008 May; 68(10):3785-94. PubMed ID: 18483262 [TBL] [Abstract][Full Text] [Related]
63. Defining early mycosis fungoides: validation of a diagnostic algorithm proposed by the International Society for Cutaneous Lymphomas. Vandergriff T; Nezafati KA; Susa J; Karai L; Sanguinetti A; Hynan LS; Ambruzs JM; Oliver DH; Pandya AG J Cutan Pathol; 2015 May; 42(5):318-28. PubMed ID: 25721994 [TBL] [Abstract][Full Text] [Related]
64. Constitutive expression of NF-kappa B is a characteristic feature of mycosis fungoides: implications for apoptosis resistance and pathogenesis. Izban KF; Ergin M; Qin JZ; Martinez RL; Pooley RJ JR; Saeed S; Alkan S Hum Pathol; 2000 Dec; 31(12):1482-90. PubMed ID: 11150373 [TBL] [Abstract][Full Text] [Related]
65. The histone deacetylase inhibitors vorinostat and romidepsin downmodulate IL-10 expression in cutaneous T-cell lymphoma cells. Tiffon C; Adams J; van der Fits L; Wen S; Townsend P; Ganesan A; Hodges E; Vermeer M; Packham G Br J Pharmacol; 2011 Apr; 162(7):1590-602. PubMed ID: 21198545 [TBL] [Abstract][Full Text] [Related]
66. Genomic imbalances and microRNA transcriptional profiles in patients with mycosis fungoides. Garaicoa FH; Roisman A; Arias M; Trila C; Fridmanis M; Abeldaño A; Vanzulli S; Narbaitz M; Slavutsky I Tumour Biol; 2016 Oct; 37(10):13637-13647. PubMed ID: 27473081 [TBL] [Abstract][Full Text] [Related]
67. Healthcare resource utilization, costs of care, and treatment of mycosis fungoides cutaneous T-cell lymphoma patterns in a large managed care population: a retrospective US claims-based analysis. Tsang Y; Gu T; Sharma G; Raspa S; Drake B; Tan H J Dermatolog Treat; 2018 Dec; 29(8):747-753. PubMed ID: 29733229 [TBL] [Abstract][Full Text] [Related]
68. Vorinostat for refractory or relapsing epidermotropic T-cell lymphoma: a retrospective cohort study of 15 patients. Kogge A; Volteau C; Saint-Jean M; Peuvrel L; Brocard A; Knol AC; Renaut JJ; Dréno B; Quéreux G Acta Derm Venereol; 2015 Jan; 95(1):72-7. PubMed ID: 24806744 [TBL] [Abstract][Full Text] [Related]
69. Unilesional mycosis fungoides: a study of seven cases. Hodak E; Phenig E; Amichai B; Feinmesser M; Kuten A; Maron L; Sahar D; Bergman R; David M Dermatology; 2000; 201(4):300-6. PubMed ID: 11146338 [TBL] [Abstract][Full Text] [Related]
70. Mycosis fungoides with epidermal mucinosis: a variant of mycosis fungoides with a spongiosis-like pattern. Hu SW; Ratech H; Naeem R; Latkowski JA; Kamino H J Cutan Pathol; 2015 Oct; 42(10):730-8. PubMed ID: 26009972 [TBL] [Abstract][Full Text] [Related]
77. A brief primer on treatments of cutaneous T cell lymphoma, newly approved or late in development. Scheinfeld N J Drugs Dermatol; 2007 Jul; 6(7):757-60. PubMed ID: 17763605 [TBL] [Abstract][Full Text] [Related]
78. IL32 is progressively expressed in mycosis fungoides independent of helper T-cell 2 and helper T-cell 9 polarization. Ohmatsu H; Humme D; Gulati N; Gonzalez J; Möbs M; Suárez-Fariñas M; Cardinale I; Mitsui H; Guttman-Yassky E; Sterry W; Krueger JG Cancer Immunol Res; 2014 Sep; 2(9):890-900. PubMed ID: 24938282 [TBL] [Abstract][Full Text] [Related]
79. Complete resolution of mycosis fungoides tumors with imiquimod 5% cream: a case series. Lewis DJ; Byekova YA; Emge DA; Duvic M J Dermatolog Treat; 2017 Sep; 28(6):567-569. PubMed ID: 28635518 [TBL] [Abstract][Full Text] [Related]
80. Overexpression of c-myb in leukaemic and non-leukaemic variants of cutaneous T-cell lymphoma. Poenitz N; Simon-Ackermann J; Gratchev A; Qadoumi M; Klemke CD; Stadler R; Kremer A; Radenhausen M; Henke U; Assaf C; Utikal J; Goerdt S; Dippel E Dermatology; 2005; 211(2):84-92. PubMed ID: 16088151 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]